# Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy

> **NCT03253744** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 17 (actual)

## Conditions studied

- Prostate Cancer
- Prostatic Neoplasm

## Interventions

- **DRUG:** 18F-DCFPyL
- **RADIATION:** Tumor Irradiation
- **RADIATION:** Prostate + tumor irradiation
- **RADIATION:** Tumor Irradiation

## Key facts

- **NCT ID:** NCT03253744
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-05
- **Primary completion:** 2023-05-03
- **Final completion:** 2025-01-30
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03253744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03253744, "Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03253744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*